Immix Biopharma Inc
(IMMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 7,663 | 6,718 | 4,683 | 4,987 | 7,395 |
| Operating Income | -7,663 | -6,718 | -4,683 | -4,987 | -7,395 |
| Other Income | 85 | 104 | 150 | 186 | 257 |
| Pre-tax Income | -7,578 | -6,614 | -4,533 | -4,801 | -7,138 |
| Income Tax | 8 | 9 | 10 | 11 | 11 |
| Net Income Continuous | -7,586 | -6,623 | -4,543 | -4,812 | -7,149 |
| Net Income | $-7,586 | $-6,623 | $-4,543 | $-4,812 | $-7,149 |
| EPS Basic Total Ops | -0.24 | -0.22 | -0.15 | -0.15 | -0.24 |
| EPS Basic Continuous Ops | -0.24 | -0.22 | -0.15 | -0.14 | -0.24 |
| EPS Diluted Total Ops | -0.24 | -0.22 | -0.15 | -0.15 | -0.24 |
| EPS Diluted Continuous Ops | -0.24 | -0.22 | -0.15 | -0.14 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.24 | -0.22 | -0.15 | -0.16 | -0.24 |
| EBITDA(a) | $-7,528 | $-6,638 | $-4,624 | $-4,946 | $-7,369 |